EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Investigation of Prognostic Factors in Patients With Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy

Akio Kimura, Akira Takekoshi, Yoichi Maekawa, Keiko Tanaka, Yoshihisa Yamano, Kuniaki Saito, Masao Takemura, Takayoshi Shimohata iD

European Journal of Neurology · 2026

DOI: 10.1111/ene.70489 ↗

At a glance

Journal article in European Journal of Neurology, 2026. Written by Akio Kimura and 7 co-authors. Institution: Department of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan. Major MEDLINE topics: Glial Fibrillary Acidic Protein, Autoimmune Diseases of the Nervous System, Astrocytes. Cited 6 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Japan Agency for Medical Research and Development.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP‐A) is a newly recognized autoimmune disorder of the central nervous system, characterized by the presence of GFAP‐IgG in the cerebrospinal fluid. Although corticosteroid therapy typically yields favorable responses, limited therapeutic efficacy is observed in some patients who subsequently develop poor clinical outcomes. This study aimed to identify prognostic factors using clinical data of patients with GFAP‐A.

Methods

This retrospective cohort study included 233 patients with GFAP‐A, who were followed up for more than 6 months. At 6 months after admission, patients were classified into unfavorable outcome [modified Rankin Scale (mRS) score ≥ 3] and favorable outcome (mRS ≤ 2) groups. Clinical data were compared between the two groups using univariate analysis. Variables that showed statistically significant differences were subsequently analyzed using multiple regression analysis to identify the individual contribution of each predictor to the unfavorable outcomes at 6 months after admission.

Results

In the multiple regression analysis, age ( p < 0.001), seizures ( p = 0.050), motor paralysis ( p = 0.042), and mRS scores at admission ( p = 0.001) were positively associated with unfavorable outcomes. In contrast, fever ( p = 0.020) was negatively associated with unfavorable outcomes.

Conclusions

In conclusion, advanced age, comorbid seizures, comorbid motor paralysis, lack of febrile episodes, and higher mRS scores at admission were associated with unfavorable outcomes in our cohort. These findings highlight the need for future studies to elucidate the underlying pathophysiological mechanisms associated with these clinical characteristics and to develop effective alternatives to corticosteroid therapy.

Subjects

MeSH terms (MEDLINE)

Glial Fibrillary Acidic ProteinAutoimmune Diseases of the Nervous SystemAstrocytesHumansFemaleMaleMiddle AgedPrognosisRetrospective StudiesAdultAgedCohort Studies

Author keywords

antibodyautoimmunitycorticosteroidglial fibrillary acidic proteinprognosis

Substances

Glial Fibrillary Acidic ProteinGFAP protein, human

Authors and institutions

  • Department of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan.
  • Department of Parasitology and Infectious Diseases, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Division of Preemptive Food Research, Preemptive Food Research Center (PFRC), Gifu University Institute for Advanced Science, Gifu, Japan.
  • Division of Animal Medical Science, COMIT, Gifu University Institute for Advanced Science, Gifu, Japan.
  • Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, School of Medicine, Fukushima, Japan.

ORCID profiles: Takayoshi Shimohata

Funding

  • Japan Agency for Medical Research and Development

Cite

APA

Kimura, A., Takekoshi, A., Maekawa, Y., Tanaka, K., Yamano, Y., Saito, K., Takemura, M., & Shimohata, T. (2026). Investigation of Prognostic Factors in Patients With Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy. European Journal of Neurology. https://doi.org/10.1111/ene.70489

Vancouver

Kimura A, Takekoshi A, Maekawa Y, Tanaka K, Yamano Y, Saito K, et al. Investigation of Prognostic Factors in Patients With Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy. European Journal of Neurology. 2026. doi:10.1111/ene.70489

BibTeX
@article{Kimura2026,
  author = {Kimura, Akio and Takekoshi, Akira and Maekawa, Yoichi and Tanaka, Keiko and Yamano, Yoshihisa and Saito, Kuniaki and Takemura, Masao and Shimohata, Takayoshi},
  title = {Investigation of Prognostic Factors in Patients With Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70489}
}
Start for free →